Diet drug dangers lead to label change, FDA announces
The Food and Drug Administration announced that the over-the-counter diet-drug Alli by local pharmaceutical powerhouse GlaxoSmithKline has changed its adjudge to warn consumers that the medication has been linked to reports of severe liver injury. Alli helps overweight people lose weight by decreasing the amount of fat absorbed by the intestines and thus reducing calorie intake. A prescription version of the drug called orlistat for the active ingredient is also acquirable at double the dosage. The prescription version is prefabricated by Roche and goes by the brand study Xenical.
Full news: Philly.com Business
